U.S. clinical trials for ALS do not include enough non-white patients and women to reflect the disease's real-world prevalence, per a study.

Scientists developed a technique to grow cells that control voluntary movement, a discovery that could aid ALS and spinal ...

Some weights weren't getting any use until columnist Dagmar Munn applied one of her "imaginary rules" toward a lesson in ...

A viral infection can trigger a neurological disease similar to amyotrophic lateral sclerosis (ALS) in mice with a specific ...

A new survey suggests many people with ALS would value even modest slowing of ALS progression as a treatment goal.

Scientists have developed a computer-based model that may explain how nerve cells become damaged in ALS, and how best to time ...

Target ALS has launched a new website that offers improved accessibility to patients, researchers, and the ALS community at ...

A new study from Sweden found long-term exposure to air pollution is linked to an increased risk of ALS and worse outcomes ...

Columnist Dagmar Munn works to restore good walking posture after recognizing that ALS-related compensations have led to ...

Columnist Kristin Neva recalls a lesson from years ago about not giving in to "what ifs" as she contends with her husband's ...

Dewpoint has selected a novel small molecule to prevent the formation of abnormal TDP-43 protein clumps in ALS and other ...

A study suggests overactive VCP may contribute to ALS nerve damage by disrupting nuclear pore proteins in genetic ALS.